[Form 4] Microvision Inc Insider Trading Activity

Rhea-AI Filing Summary

MicroVision (MVIS) CEO Sumit Sharma reported routine equity-compensation activity in a Form 4 dated 24-25 Jul 2025. Two tranches of restricted stock units vested, converting into 746,250 common shares at no cost (unit-for-share). His direct holding temporarily increased to 1,644,671 shares.

On 25 Jul the issuer executed a nondiscretionary sell-to-cover for withholding taxes, disposing of 341,931 shares at a weighted-average price of $1.3182 (range $1.2801-$1.37). After the sale Sharma holds 1,302,740 shares directly, with no derivative securities remaining from the reported grants.

The transactions add a net ~29 000 shares to the CEO’s stake, signalling continued alignment with shareholders; the tax-related sale is typical and does not suggest discretionary selling pressure.

Positive

• Net increase of approximately 29,000 shares in CEO direct ownership, modestly boosting insider alignment with shareholders.
• Performance-verified RSU vesting demonstrates linkage between executive pay and company goals.

Negative

• 341,931 shares sold into the market for tax withholding, adding minor short-term selling pressure.

Insights

Securities Analyst

TL;DR: Routine RSU vesting; minor net share gain; neutral market impact.

The filing reflects standard executive compensation mechanics. Although 341,931 shares were sold, the proceeds covered taxes rather than indicating bearish sentiment. Sharma’s net ownership rose to 1.30 M shares, a modest 2% increase versus the mid-July figure, maintaining insider alignment. Volume of the sell-to-cover is small relative to MVIS’s average daily volume, limiting price pressure. No new options were granted; all reported RSUs are now settled. Overall, the disclosure is operational, not a directional signal.

Corporate Governance Specialist

TL;DR: Compensation plan working as designed; governance risk unchanged.

The one-year performance-based RSUs vested only after Compensation Committee certification, illustrating adherence to pay-for-performance policy. The staggered 2024-2027 RSU schedule provides multi-year retention incentives. Sell-to-cover aligns with best practice by preventing open-market cash demands on the executive. Because no discretionary sales occurred, governance risk—often tied to insider selling—remains stable.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Sharma Sumit

(Last) (First) (Middle)

18390 NE 68TH STREET

(Street)

REDMOND WA 98052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	07/24/2025		M		375,000	A	$0.00	1,273,421	D
Common Stock(1)	07/24/2025		M		371,250	A	$0.00	1,644,671	D
Common Stock(2)	07/25/2025		F		341,931	D	$1.3182(3)	1,302,740	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.00(4)	07/24/2025		A		375,000		07/24/2025(5)	07/24/2025	Common stock	375,000	$0.00	375,000	D
Restricted Stock Units	$0.00(6)	07/24/2025		M			375,000	07/24/2025(5)	07/24/2025	Common stock	375,000	$0.00	0	D
Restricted Stock Units	$0.00(6)	07/24/2025		M			371,250	07/24/2025(7)	07/24/2025	Common stock	371,250	$0.00	0	D

Explanation of Responses:

1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.

2. Represents a withholding tax-related nondiscretionary sell-to-cover transaction completed by the Issuer in accordance with the terms of the award agreement.

3. The price reported in column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $1.2801 to $1.37, inclusive.

4. Each RSU represents a contingent right to receive one share of MicroVision common stock.

5. RSUs vested on July 24, 2025, on the one-year anniversary of grant, upon determination by the Issuer's Compensation Committee of the level of achievement of performance objectives pursuant to the 2024 Executive Bonus Plan.

6. At vesting, converts into shares of common stock on a unit-for-share basis.

7. On July 27, 2024, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on July 27, 2027, subject to the Reporting Person's continued employment with the Issuer on each vesting date.

	/s/ Drew G. Markham, as attorney-in-fact	07/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many MicroVision shares did CEO Sumit Sharma acquire?

He received 746,250 shares upon RSU vesting on 24 Jul 2025.

Why were 341,931 MVIS shares sold on 25 Jul 2025?

The shares were sold in a nondiscretionary sell-to-cover transaction to satisfy withholding taxes.

What is Sharma's current direct ownership in MVIS?

After the reported transactions he holds 1,302,740 common shares.

At what price were the tax-related shares sold?

The weighted-average sale price was $1.3182, with trades ranging $1.2801-$1.37.

Do any RSUs remain unsettled after this Form 4?

No. The RSUs reported in Table II were fully settled or forfeited, leaving 0 derivative units from those grants.